Europe — EMA

Oxaliplatina Accord

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatina Accord, is a platinum-based antineoplastic agent presented as a unknown/unknown for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Oxaliplatina Accord as a licensed, GDP‑compliant international ...

What is Oxaliplatin used for?

Oxaliplatin ... ... .... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →